To investigate whether there is any relationship between cord blood theophylline levels and pulmonary morbidities in the early neonatal period in premature infants.
levels of methylxanthines vary, depending on the amount of their consumption in the daily diet (5) . Methylxanthines are rapidly and completely absorbed from the gastrointestinal tract and penetrate all tissues, including blood-brain and placenta barriers (1, 2) . Caffeine is mainly metabolized by the cytochrome P450 1A2 (CYP1A2), and another enzyme that regulates the metabolism to a lesser extent is N-acetyltransferase (2, 6) . Since activities of both these enzymes decrease during pregnancy, concentrations of caffeine gradually increase, leading to an accumulation of caffeine in the mother and fetus (2) . Caffeine and its metabolites, such as paraxanthine, theophylline and theobromine, easily pass fetal circulation via the placenta. There are no significant differences in plasma levels of theophylline between the maternal and fetal circulations (2) . However, it is not known what effects caffeine and its metabolites, which are taken through the maternal diet during the fetal period, have on the respiratory system in the early neonatal period.
In this study, we aimed to investigate whether there is any relationship between cord blood theophylline levels and pulmonary morbidities in the early neonatal period in premature infants.
Introduction
Caffeine and theophylline are widely used drugs in the treatment of apnea of prematurity. As respiratory stimulants, they are also used to weaning from mechanical ventilation (1, 2) . These drugs and their precursors are taken in via certain daily foods. Methylxanthines such as caffeine and its metabolites (paraxanthine, theophylline, and theobromine) are available in tea, coffee, cocoa, cola, and chocolate (3, 4) . Plasma the institutional ethical committee. After parental informed consent, cord blood samples were collected at birth from premature infants whose gestational ages were under 37 weeks, and theophylline levels were measured. Infants with congenital anomalies and chromosomal disorders were excluded from the study. Cord blood samples (1 mL) were taken from the infants. Sera of blood samples were separated and theophylline levels were measured in µg/ml, using the ultraviolet spectrophotometric method. Pulmonary morbidities occurring in the first week of life in infants, such as transient tachypnea of newborn (more than 60 breaths per minute, less than 24 hours), respiratory distress syndrome (RDS, defined as respiratory findings, typical radiological findings, oxygen or mechanical ventilation requirement, surfactant requirement), apnea (defined as cessation of breathing for more than 20 seconds, or a shorter respiratory pause associated with oxygen desaturation and/or bradycardia), congenital pneumonia, and the requirement of ventilation with positive pressure etc., were recorded. Theophylline levels of cord blood were compared between infants with and without pulmonary morbidity. The Helsinki Declaration rules were complied with during this study. PASW 18 for Windows (Chicago, USA) was used for the statistical analysis. Normally distributed variables were evalu-ated by parametric tests, while non-normally distributed variables were evaluated by non-parametric tests. Categorical and qualitative variables were analyzed by χ 2 test and Fisher's exact χ 2 test. P value <0.05 were considered statistically significant.
Results
A total of 90 infants (42 females, 48 males) were enrolled in the study. The mean gestational age was 31.1±3.1 weeks (range: 24-36 weeks), and the mean birth weight was 1527±540 g (range: 530-2810 g). Early respiratory morbidities developed in 57 infants (Group 1, 63.3%), while no respiratory morbidities were observed in 33 infants (Group 2, 36.7%). Although mean cord blood theophylline levels were lower in Group 1 (0.22±0.17 µg/mL) than Group 2 (0.23±0.29 µg/mL), this difference was not statistically significant (p=0.531). Table  I shows the comparison of cord blood theophylline levels between the subgroups created according to the neonatal features and respiratory parameters. There was no significant difference in blood gas parameters, oxygen saturation values, the incidence of RDS, the need of mechanical ventilation in the first 48 hours, duration of mechanical ventilation and oxygen support, the incidence of apnea, postnatal age of introducing methylxanthine (caffeine or theophylline) treatment, duration of hospi- .027 Type of delivery (NSVD/CS), n (%) 4 (7.0) / 53 (93.0) 0 (0) / 33 (100) .292 Apgar score (5th min)* 7 (5-10) 9 (6) (7) (8) (9) (10) .000 Resuscitation at birth, n (%) 36 (63.2) 2 (6.1) .000 Cord blood pH** 7.27 ± 0.08 7.22 ± 0.11 .216 Apnea, n (%) 25 (43.9) talization, and cord blood theophylline levels. In the study group, theophylline level in the cord blood of 29 infants was 0. Between this group and the remaining 61 infants, there was no significant difference in respiratory morbidities.
All infants with and without respiratory problems were matched according to similar gestational ages, forming two new subgroups (Group 1b [n=20], Group 2b [n=20]); no significant difference in cord blood theophylline levels was detected between these two subgroups. The comparison of the demographic, neonatal and clinical features of infants with or without respiratory distress in the new subgroups formed according to similar gestational ages is shown in table II.
In the study group, theophylline was present in the cord blood of 61 infants (Group 2c), while it was absent in the other 29 infants (Group 1c). We found no significant difference between the two new groups with respect to the demographic, neonatal and clinical features of infants, except for respiratory distress. Surprisingly, respiratory distress was significantly higher in Group 2c than Group 1c. Table III shows the comparison of the demographic, neonatal and clinical features of infants with or without respiratory distress in subgroups created according to the presence or not of theophylline in the cord blood.
Discussion
In this prospective observational study, we showed that there is no relationship between cord blood theophylline levels and pulmonary morbidities in the early neonatal period in premature infants. In every period of pregnancy, methylxanthines can pass easily through the placenta, and can reach maternal levels in infants. Both the fetus and placenta lack the enzymes needed to metabolize methylxanthines, and therefore, elimination in the fetus is almost entirely dependent upon renal excretion without any change in their composition (2) . The enzyme activity of CYP1A2 reaches the adult level only in the postnatal 3 rd -8 th month. Consequently, half-lives of methylxanthines are longer in newborns than adults (theophylline 20-30 hours, caffeine 40-230 hours). The chemical composition of theophylline, its effect mechanism and biological effects are similar to those of caffeine (1, 2) . Furthermore, some amount of theophylline is converted to caffeine via back-methylation reaction. The obvious effect of methylxanthines may be the same, since caffeine and theophylline exert similar biologic actions. The half-life of theophylline in premature infants is 20-30 hours. Therapeutic blood levels of methylxanthines are 5-25 mg/L for caffeine and 6-12 mg/L for theophylline (1, 2) . In studies conducted on animals, it was reported that the use of maternal aminophylline increases the levels of phospholipid in fetal lungs (7, 8) , while in premature infants, treatment with postnatal caffeine and theophylline improves pulmonary outcomes, reduces the risk of bronchopulmonary dysplasia and has beneficial effects on cognitive outcomes (1,2). A significant teratogenic effect of caffeine and theophylline intake has not been detected in epidemiologic studies in humans (9, 10) . Some epidemiological studies have shown that excessive maternal consumption of caffeine in humans (more than >300 mg/day) may be related to reduced fertility and may increase the risk of spontaneous abortions, intrauterine growth restriction and stillbirth (11) (12) (13) (14) (15) (16) (17) (18) (19) . On the other hand, major effects of caffeine on fetal growth restriction, low birth weight and preterm delivery have not been shown in several prospective epidemiologic studies (15) . There have been a few studies on the perinatal outcomes in newborns of mothers treated with theophylline, but no relation between theophylline and low birth weight and prematurity were found (2, 6, 10) . In our study, determining the exact amount of food containing methylxanthines in the daily diets of the mothers was not possible. Furthermore, since methylxanthine levels are the same in each mother and her infant, only the infants' cord blood methylxanthine levels were studied. Caffeine and its primary metabolites, paraxanthine, theobromine, and theophylline, are detectable in all body fluids and in the umbilical cord blood (5, 6) . However, until the present study, there had been no study investigating the relationship between cord blood theophylline levels and respiratory morbidities in the early neonatal period in premature infants. In this study, mean cord blood theophylline levels were determined as 0.23±0.22 µg/mL.
The amount of methylxanthines that passes from mother to infant depends on the mother's diet. Consumption of beverage contains caffeine (especially coffee, cola etc.) and chocolate is higher in developed countries (3) (4) (5) . In our country, it is thought that these kinds of foods and drinks are consumed to a lesser extent for cultural reasons. Since a questionnaire assessment of methylxanthine exposure does not provide an accurate measurement of maternal or fetal dose and since there are no differences between maternal and fetal methylxanthine levels, we measured cord blood theophylline levels.
In the study group, theophylline level in the cord blood of 29 (32.2%) infants was 0. Between this group (29 infants, Group 1c) and the remaining infants [61 infants (67.8%), Group 2c], there was no significant difference in blood gas parameters, oxygen saturation values, the incidence of RDS, need of mechanical ventilation in the first 48 hours, duration of mechanical ventilation and oxygen support, the incidence of apnea, postnatal age of introducing methylxanthine (caffeine or theophylline) treatment, and duration of hospitalization. However, respiratory distress was significantly higher in .008
Group 2c than Group 1c. This result may suggest that low levels of cord blood theophylline might not affect the early respiratory morbidities in premature infants.
In a few experimental studies, it was reported that aminophylline administration significantly increased the amount of fetal lung phospholipid in rabbits and rats, but it had no effect on the surfactant system (7, 8, 20, 21) . In this study, we did not find any correlation between cord blood theophylline levels and the need for resuscitation at birth or need of mechanical ventilation in the first 48 hours, regardless of the presence or not of RDS and apnea. We thought that they had no effect on the respiratory system, as theophylline levels in the cord blood were fairly low, and the effects of methylxanthines are identified in pharmacological doses.
Based on the results of this study, we did not find any correlation between the cord theophylline levels and early pulmonary morbidities in premature infants. Although the theophylline levels that were measured in the cord blood were much lower than therapeutic serum levels, we concluded that the cord theophylline level is not valuable as a prognostic factor for pulmonary morbidities in premature newborns. Further experimental studies are needed to determine the levels of theophylline that provides fetal lung maturation. 
